SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: Immunomedics (IMMU) - moderated

20 Oct 2022 10:42 PM <--
18 Dec 2020 06:56 PM
02 Sep 2020 07:03 PM
28 Aug 2020 10:59 PM
19 Aug 2020 02:21 PM
17 Jul 2020 01:47 PM
29 Jun 2020 11:30 AM
06 May 2020 09:45 PM
06 May 2020 02:45 PM
06 May 2020 01:08 PM
28 Nov 2018 06:58 PM
27 Nov 2018 10:59 PM
16 Aug 2018 01:37 PM
02 Aug 2018 02:20 PM
02 Aug 2018 12:37 PM
18 Jul 2018 10:49 AM
23 May 2018 11:21 PM
15 Dec 2016 12:56 PM
24 Aug 2014 10:16 AM
13 Jun 2013 08:03 AM
05 Jul 2011 10:42 AM
13 Oct 2010 10:05 AM
10 Oct 2010 10:39 AM
08 Mar 2010 08:32 AM
25 Nov 2009 03:28 PM
27 Oct 2009 09:05 PM
25 Oct 2009 06:57 PM
29 May 2009 02:59 PM
01 Mar 2009 10:32 AM
28 Nov 2007 08:09 PM
09 Apr 2007 08:32 PM
15 Feb 2007 09:40 PM
07 Jan 2007 10:29 AM
12 Dec 2006 08:08 AM
08 Nov 2006 09:32 PM
08 Oct 2006 07:47 PM
05 Oct 2006 07:43 AM
09 Sep 2006 08:57 PM

Return to Immunomedics (IMMU) - moderated
 
Welcome to the troll-free, moderated message board, made up of primarily ex-IMMU shareholders.
- IMMU's status:
--It is now a fully owned subsidiary of Gilead.

This board of ex IMMU shareholders who have gained the respect and trust of each other over many frustrating years of disappointment and heartache, yet having a thrilling ending, who still like to check in on what each other is thinking about other biotech investments. On the downside, the IMMU buyout was one of the last positive events in biotech before falling out of favor as a sector, and the efforts to turn some of the cash from the buyout into more growth has been a rough patch. However, most of us have gone through very rough and long periods of frustration and so most are experienced and seem to be mentally weathering this rough patch rather well.

Hopefully the combined knowledge and wisdom on this board will be financially beneficial over time in the biotech sector. I continue to monitor the board to keep it at the highest level that it has attained.

Etiquette:

This board is moderated, meaning the moderator (me) can stop people from posting here if they violate our norms. What are "our norms"? Well, be adult, play nice about sums it up. There are three responses I encourage for keeping the discussion civil and useful when you encounter a post that annoys you. In order of preference:

1> report a ToU violation to the SI admins via the link at the bottom of each post, they're good at dealing with problems.

2> send the person who posted a private message and work it out. Privately.

3> send me a private message. Wait a couple of days before doing so please, I'll usually see the message in that time frame and act (or not).

4> stay focused and leave politics out of it, even by inference. There are numerous forums you can spend as much time expounding on your favorite "why (insert favorite hot-button) is evil", we don't need to reiterate all that here.

5> do not engage in discussions about poster's motivations, etc. First of all, it's unprovable. Second I'd rather not wade through the inevitable pointless back-and-forth over something that'll never be settled anyway.

This board provides a forum for honest, civilized and friendly conversation. It is not a vehicle for spam or hidden agendas. New posters are not only welcome but are an important way to bring additional information and insights to the board. Over the years new posters have been welcomed into the group and have helped make the board successful. However, if you’re a new poster it is especially important to be sure that material assertions, be they pro or con, are thoughtful and supportable. While all posters must abide by the TOU, leeway can and will be granted to long-time posters who have made substantive contributions to the board and whose credibility has been established.